CV/COS Webinar: Clip 9

In the world of cancer care, different disease stages present unique challenges and experiences for patients. At Carevive, we recognize the importance of considering the stage of disease when analyzing the impact and quantification of tolerability, physical function, and symptoms. Early-stage disease patients may not be symptomatic, and treatment administration may have minimal interference as they work towards remission or cure. Real-world data collection allows us to gain valuable insights into the varying needs and experiences of patients at different stages, enabling us to tailor care strategies to meet their specific requirements and improve overall outcomes.

Recent Episodes

Economic mobility is often portrayed as a straight climb. In reality, it’s shaped by adversity, identity, and access to opportunity. As research from the University of Michigan notes, mobility requires not only income, education, and employment, but also more intangible resources such as social inclusion and power—the ability to make choices and exert influence….

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers…

Generative AI has captured the public imagination, but its most transformative use cases may lie far from flashy consumer tools. In healthcare operations, where complexity, inefficiency, and fragmentation remain persistent challenges, AI is now driving measurable improvements. Research suggests AI-enabled healthcare systems could cut administrative costs by up to $360 billion in the U.S. alone….